Literature DB >> 30014542

The judgements that evidence-based medicine adopts.

Elena Rocca1.   

Abstract

In "The evidence that evidence-based medicine omits", Brendan Clarke and colleagues argue that when establishing causal facts in medicine, evidence of mechanisms ought to be included alongside evidence of correlations. One of the reasons they provide is that correlations can be spurious and generated by unknown confounding variables. A causal mechanism can provide a plausible explanation for the correlation, and the absence of such an explanation is an indication that the correlation is not causal. Evidence-based medicine (EBM) proponents remain sceptical about this argument, one problem being that the formulation of a mechanism requires judgements that are external to the evaluation of data and experimental designs-for instance judgements of plausibility against, or derivability from, background knowledge. Because background knowledge is always incomplete and therefore unreliable, EBM proponents maintain that the plausibility of a hypothesis should be evaluated mainly by the quality of population data that yielded it. Here, I use the example of oestrogen replacement therapy's effect on coronary heart disease, an example that is often quoted in defence of the epistemic advantage of randomized controlled trials, to show that the evaluation of the most reliable study design necessarily implies the adoption of judgements that are external to the specific evidence of correlation. The exclusion of evidence of mechanism, therefore, is not effective in bypassing paradigm-dependent judgements, which are external to specific evidence. Because such judgements cannot be excluded by evidence evaluation, they can only be kept under scrutiny, or adopted uncritically. I propose that the latter option can hinder the maintenance of an active critical inquiry, as well as the analysis of experts' disagreement.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  decision-making; evidence evaluation; mechanism; medicine; statistical evidence

Mesh:

Year:  2018        PMID: 30014542     DOI: 10.1111/jep.12994

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  5 in total

Review 1.  Pharmacovigilance as Scientific Discovery: An Argument for Trans-Disciplinarity.

Authors:  Elena Rocca; Samantha Copeland; I Ralph Edwards
Journal:  Drug Saf       Date:  2019-10       Impact factor: 5.606

2.  The failure of drug repurposing for COVID-19 as an effect of excessive hypothesis testing and weak mechanistic evidence.

Authors:  Mariusz Maziarz; Adrian Stencel
Journal:  Hist Philos Life Sci       Date:  2022-10-18       Impact factor: 1.452

3.  On evidence fiascos and judgments in COVID-19 policy.

Authors:  Saana Jukola; Stefano Canali
Journal:  Hist Philos Life Sci       Date:  2021-04-16       Impact factor: 1.205

4.  Agent-based modelling for SARS-CoV-2 epidemic prediction and intervention assessment: A methodological appraisal.

Authors:  Mariusz Maziarz; Martin Zach
Journal:  J Eval Clin Pract       Date:  2020-08-21       Impact factor: 2.336

Review 5.  The Emperor's New Clothes: a Critical Appraisal of Evidence-based Medicine.

Authors:  Giovanni D Tebala
Journal:  Int J Med Sci       Date:  2018-09-07       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.